Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study.
Author | |
---|---|
Abstract | :
We examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM). |
Year of Publication | :
2018
|
Journal | :
Journal of the American Heart Association
|
Volume | :
7
|
Issue | :
3
|
Date Published | :
2018
|
URL | :
http://jaha.ahajournals.org/cgi/pmidlookup?view=long&pmid=29367417
|
DOI | :
10.1161/JAHA.117.007393
|
Short Title | :
J Am Heart Assoc
|
Download citation |